ARTICLE
29 March 2022

Health Law Diagnosed — Transactions Part 2: The Role Of Health Regulatory Diligence And How To Prepare For A Sell-Side Transaction (Podcast)

M
Mintz

Contributor

Mintz is a litigation powerhouse and business accelerator serving leaders in life sciences, private equity, sustainable energy, and technology. The world’s most innovative companies trust Mintz to provide expert advice, protect and monetize their IP, negotiate deals, source financing, and solve complex legal challenges. The firm has over 600 attorneys across offices in Boston, Los Angeles, Miami, New York, Washington, DC, San Francisco, San Diego, and Toronto.
Health regulatory diligence has the ability to make or break a deal.
United States Food, Drugs, Healthcare, Life Sciences

Health Law Diagnosed · Transactions Part 2: Health Regulatory Diligence and How to Prepare for a Sell-Side Transaction

Health regulatory diligence has the ability to make or break a deal. Listen to hear about our team's firsthand experience in the importance of conducting health regulatory diligence and best practices in preparing for a sell-side transaction.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More